The CINOD, AZD3582, exhibits an improved gastrointestinal safety profile compared with naproxen in healthy volunteers

Author： Jonzon Bror  

Publisher： VSP

ISSN： 1568-5608

Source： Inflammopharmacology, Vol.11, Iss.4-6, 2003-12, pp. : 437-444

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Naproxcinod: AZD 3582, HCT 3012, Naproxen Nitroxybutylester, Nitronaproxen, NO-Naproxen

By Adis International Limited  

Drugs in R&D, Vol. 8, Iss. 4, 2007-01 ,pp. : 255-258

Adis International

Access to resources Recommend Favorite

Nitronaproxen: AZD 3582, HCT 3012, Naproxen Nitroxybutylester, NO-Naproxen

By Adis International Limited  

Drugs in R&D, Vol. 7, Iss. 4, 2006-01 ,pp. : 262-266

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Safety of Ebastine in Patients with Impaired Hepatic Function Compared with Healthy Volunteers: A Phase I Open-Label Study

By Lasseter K.C.  

Clinical Pharmacokinetics, Vol. 43, Iss. 2, 2004-01 ,pp. : 121-129

Adis International

Access to resources Recommend Favorite

GCG100649, A Novel Cyclooxygenase‐2 Inhibitor, Exhibits a Drug Disposition Profile in Healthy Volunteers Compatible With High Affinity to Carbonic Anhydrase‐I/II: Preliminary Dose–Exposure Relationships to Define Clinical Development Strategies

By  

Clinical Pharmacology In Drug Development, Vol. 2, Iss. 4, 2013-10 ,pp. : 379-386

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety, pharmacokinetics and pharmacodynamics of atacicept in healthy volunteers

By Munafo Alain   Priestley Anthony   Nestorov Ivan   Visich Jennifer   Rogge Mark  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 7, 2007-07 ,pp. : 647-656

Springer Publishing Company

Access to resources Recommend Favorite